Filter
977
Text search:
global
modelling
study
Featured
100
180
Language
Document type
338
320
168
51
43
29
12
10
2
1
Countries
78
33
22
19
17
16
15
14
12
12
11
11
10
10
10
10
9
8
8
8
8
7
7
7
7
7
7
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
228
99
71
43
36
11
6
Toolboxes
156
101
94
54
54
36
31
27
27
27
22
21
20
20
17
13
11
9
7
7
6
5
2
2
1
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Eur Respir J. 2014 April ; 43(4): 1132–1141. doi:10.1183/09031936.00203613.
DHS Analytical Studies No. 40
DHS Further Analysis Reports No. 101
DHS Working Papers No. 120
International Development vol. 11. DOI 10.4073/csr.2015.15
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The State of the World's Midwifery
A survey of prevention, testing and treatment policies and practices
